1. Home
  2. LWLG vs DBVT Comparison

LWLG vs DBVT Comparison

Compare LWLG & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

N/A

Current Price

$3.01

Market Cap

625.9M

Sector

Industrials

ML Signal

N/A

Logo DBV Technologies S.A.

DBVT

DBV Technologies S.A.

N/A

Current Price

$9.51

Market Cap

692.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LWLG
DBVT
Founded
1991
2002
Country
United States
France
Employees
N/A
90
Industry
Containers/Packaging
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
625.9M
692.2M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
LWLG
DBVT
Price
$3.01
$9.51
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$7.00
★ $36.51
AVG Volume (30 Days)
★ 3.6M
293.9K
Earning Date
11-10-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 15.79
10.26
EPS
★ N/A
N/A
Revenue
$236,855.00
★ $5,636,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$257.14
$1,837.59
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 147.74
35.77
52 Week Low
$2.83
$8.63
52 Week High
$18.71
$26.19

Technical Indicators

Market Signals
Indicator
LWLG
DBVT
Relative Strength Index (RSI) 33.95 41.29
Support Level N/A $8.78
Resistance Level $5.73 $10.86
Average True Range (ATR) 0.45 0.78
MACD -0.12 -0.06
Stochastic Oscillator 8.79 18.20

Price Performance

Historical Comparison
LWLG
DBVT

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: